JP2006188525A5 - - Google Patents

Download PDF

Info

Publication number
JP2006188525A5
JP2006188525A5 JP2006016490A JP2006016490A JP2006188525A5 JP 2006188525 A5 JP2006188525 A5 JP 2006188525A5 JP 2006016490 A JP2006016490 A JP 2006016490A JP 2006016490 A JP2006016490 A JP 2006016490A JP 2006188525 A5 JP2006188525 A5 JP 2006188525A5
Authority
JP
Japan
Prior art keywords
trimethoxyphenyl
methyl
sulfonamide
trimethoxy
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006016490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006188525A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2006188525A publication Critical patent/JP2006188525A/ja
Publication of JP2006188525A5 publication Critical patent/JP2006188525A5/ja
Pending legal-status Critical Current

Links

JP2006016490A 1999-05-28 2006-01-25 細胞増殖抑制剤 Pending JP2006188525A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32233999A 1999-05-28 1999-05-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005174115A Division JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤

Publications (2)

Publication Number Publication Date
JP2006188525A JP2006188525A (ja) 2006-07-20
JP2006188525A5 true JP2006188525A5 (enExample) 2007-05-31

Family

ID=23254447

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000621331A Expired - Fee Related JP3702183B2 (ja) 1999-05-28 2000-05-26 細胞増殖抑制剤
JP2005174115A Expired - Fee Related JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤
JP2006016490A Pending JP2006188525A (ja) 1999-05-28 2006-01-25 細胞増殖抑制剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2000621331A Expired - Fee Related JP3702183B2 (ja) 1999-05-28 2000-05-26 細胞増殖抑制剤
JP2005174115A Expired - Fee Related JP3869847B2 (ja) 1999-05-28 2005-06-14 細胞増殖抑制剤

Country Status (16)

Country Link
EP (1) EP1181269B1 (enExample)
JP (3) JP3702183B2 (enExample)
AR (1) AR024138A1 (enExample)
AT (1) ATE260248T1 (enExample)
AU (1) AU5170900A (enExample)
BR (1) BR0007589A (enExample)
CA (1) CA2371092A1 (enExample)
CO (1) CO5170498A1 (enExample)
DE (1) DE60008527T2 (enExample)
DK (1) DK1181269T3 (enExample)
ES (1) ES2215668T3 (enExample)
HK (1) HK1045299B (enExample)
MX (1) MXPA01012226A (enExample)
PT (1) PT1181269E (enExample)
TW (1) TWI221837B (enExample)
WO (1) WO2000073264A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147890A0 (en) * 1999-07-29 2002-08-14 Tularik Inc Pharmaceutical compositions containing pentafluorobenzenesulfonamide derivatives
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
AU2002234165A1 (en) 2000-11-03 2002-05-27 Tularik, Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
MXPA03005696A (es) * 2000-12-21 2003-10-06 Glaxo Group Ltd Pirimidinaminas como moduladores de angiogenesis.
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
EP1463505A2 (en) * 2001-12-13 2004-10-06 Abbott Laboratories 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
FR2836914B1 (fr) 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
JP2008546837A (ja) * 2005-06-28 2008-12-25 メルク エンド カムパニー インコーポレーテッド 非ヌクレオシド逆転写酵素阻害剤
AU2006315436A1 (en) * 2005-11-15 2007-05-24 Vertex Pharmaceuticals Incorporated Azaindazoles useful as inhibitors of kinases
US20110053995A1 (en) * 2006-11-16 2011-03-03 The Regents Of The University Of California Benzenesulfonanilide compound inhibitors of urea transporters
JPWO2008114831A1 (ja) * 2007-03-20 2010-07-08 国立大学法人 岡山大学 スルホンアミド基を有する抗菌剤
JP5302328B2 (ja) 2007-11-21 2013-10-02 オキシジーン, インコーポレイテッド 造血性新生物を治療するための方法
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
US9034875B2 (en) 2009-05-26 2015-05-19 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8546399B2 (en) 2009-05-26 2013-10-01 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US20220315555A1 (en) 2009-05-26 2022-10-06 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US20130109672A1 (en) 2010-04-29 2013-05-02 The United States Of America,As Represented By The Secretary, Department Of Health And Human Service Activators of human pyruvate kinase
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
WO2014144715A1 (en) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Hsp90-targeted cardiac imaging and therapy
FR3030516B1 (fr) * 2014-12-19 2019-12-27 Galderma Research & Development Derives sulfonamides bicycles en tant qu'agonistes inverses du recepteur gamma orphelin associe aux retinoides ror gamma (t)
JP2018523712A (ja) 2015-08-18 2018-08-23 マテオン セラピューティクス, インク.Mateon Therapeutics, Inc. 腫瘍に対する免疫調節療法を向上させる為のvdasの使用
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
WO2020247054A1 (en) 2019-06-05 2020-12-10 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
WO2022182415A1 (en) 2021-02-24 2022-09-01 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4013621A (en) * 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
IT1050750B (it) * 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives
GB8804457D0 (en) * 1988-02-25 1988-03-23 Ciba Geigy Ag Compositions
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
JPH04202173A (ja) * 1990-11-30 1992-07-22 Zeria Pharmaceut Co Ltd スルホンアミド誘導体及びそれを含有する5―リポキシゲナーゼ阻害剤
GB9200415D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Inactivation of cytotoxic drugs
JPH06206805A (ja) * 1992-02-17 1994-07-26 Hisamitsu Pharmaceut Co Inc チロシナーゼ阻害剤及びそれを用いた皮膚外用剤
JPH06199047A (ja) * 1993-01-08 1994-07-19 New Oji Paper Co Ltd 感熱記録体
JPH08176113A (ja) * 1993-11-12 1996-07-09 Dainippon Pharmaceut Co Ltd 2−スルフィニルニコチンアミド誘導体及びその中間体並びにそれを有効成分とする消化性潰瘍治療薬
JPH09179257A (ja) * 1995-12-22 1997-07-11 Konica Corp ハロゲン化銀カラー写真感光材料
DE69724811T2 (de) * 1996-07-19 2004-04-08 Tularik, Inc., South San Francisco Pentafluorobenzensulfonamide und analoge
BR9714087A (pt) * 1996-12-27 2000-05-09 Daiichi Seiyaku Co Derivados de propionil substituìdo.
JPH10316650A (ja) * 1997-05-13 1998-12-02 Dev Center For Biotechnol 新規な抗アテローム性動脈硬化薬
EA200800375A1 (ru) * 1997-05-14 2008-06-30 Атеродженикс, Инк. Соединения и способы ингибирования экспрессии vcam-1
US6191170B1 (en) * 1998-01-13 2001-02-20 Tularik Inc. Benzenesulfonamides and benzamides as therapeutic agents
WO1999067258A1 (en) * 1998-06-25 1999-12-29 Tularik Inc. Arylsulfonanilide phosphates
CA2350316A1 (en) * 1998-11-09 2000-05-18 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels

Similar Documents

Publication Publication Date Title
RU2337098C2 (ru) Новые производные бензимидазола и фармацевтическая композиция на их основе для использования в лечении расстройств, опосредованных vr1
FI108792B (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten furanonijohdannaisten valmistamiseksi
JP3869847B2 (ja) 細胞増殖抑制剤
JP2005522438A5 (enExample)
RU2011101951A (ru) Способ получения стимулятора апоптоза авт-263
ES2675074T3 (es) Compuestos de aril-fenil-sulfonamida-fenileno y su uso
JP2015510886A5 (enExample)
PE20040775A1 (es) DERIVADOS DE INDOL COMO AGONISTAS DE ADRENORECEPTORES ß2
KR101063462B1 (ko) 아릴 및 헤테로아릴 프로펜 아미드, 이들의 유도체 및 이의치료학적 용도
RU2389719C2 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
SK110198A3 (en) Il-8 receptor antagonists, method for the preparation thereof, pharmaceutical composition and use
US8293513B2 (en) Histone deacetylase inhibitors
JP2010526025A5 (enExample)
CY1109409T1 (el) Κρυσταλλοι παραγωγου υδροξυνορεφεδρινης
WO2007120379A3 (en) Sulfonanilide analogs as selective aromatase modulators
JP2005530852A5 (enExample)
ES2386811T3 (es) Ácidos sulfónicos, sus derivados y composiciones farmacéuticas que los contienen
RU2008149936A (ru) (2r)-2-[(4-сульфонил)аминофенил]пропанамиды и содержащие их фармацевтические композиции
JP2004524345A5 (enExample)
JP2002501043A5 (enExample)
CA2659746A1 (en) Aryl vinyl sulfides, sulfones, sulfoxides and sulfonamides, derivatives thereof and therapeutic uses thereof
JP2005521664A5 (enExample)
JP4538233B2 (ja) 増殖性障害治療用の、アミノ置換されたスルホンアニリド及びその誘導体
JP2007501790A5 (enExample)
JP2007513877A5 (enExample)